Stock market rebound: I’d buy these FTSE 100 bargains

Three cyclical FTSE 100 shares that could participate in the stock market rebound when the green shoots begin to appear after this coronavirus crisis.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

Here are three cyclical FTSE 100 shares that could participate in the stock market rebound when the green shoots begin to appear after this coronavirus crisis.

Hospitality

In an update on March 24, Whitbread (LSE: WTB) told us that most of its hotel, pub and restaurant operations had been closed to comply with social-distancing requirements. Indeed, the effects of the coronavirus pandemic have been dramatic for the hospitality company.

To help Whitbread survive the crisis, the directors have taken several actions. For example, they’ve put most of the staff on temporary furlough with the aim of collecting financial support from the government. And they’ve stopped all non-essential expenditure and investment. It almost goes without saying that the shareholder dividend for the full-year to February 2020 has been a casualty of the cuts.

Now it’s a game of waiting. In the meantime, the directors reckon the company has “material headroom” on its funding facilities. And a “valuable” freehold property estate backs the business. My guess is that the cost-cutting will combine with government support measures to see the company through the crisis. When social-distancing measures ease, we could see a return to trading and a resurgence in the fallen share price. 

Insurance

Aviva (LSE: AV) said on 8 April that it has no intention of using the government scheme to furlough its employees. Since the crisis began, the firm’s staff have “maintained high service standards” to customers across all the company’s markets. 

But the directors have axed the final dividend for 2019. They said in the update it’s too early to quantify the effects of the crisis on claims expenses in the company’s life and general insurance businesses. Neither can they estimate how much damage the weakness in the stock market will cause Aviva’s financial results. But because of the deterioration of the general economic outlook, the directors are reviewing all “material discretionary and project expenditure.” 

The company’s trading performance is closely linked with the health of the general economy and financial markets. When conditions improve, I reckon we could see Aviva’s share price rebound as well.

Engineering

International engineering company Meggitt (LSE: MGGT) updated investors on March 27. The company specialises in high-performance components and sub-systems for the aerospace, defence and some energy markets. The business is suffering from the reduction in air traffic in 2020 and a decrease in demand for original equipment and aftermarket services. 

The directors have taken a series of actions to reduce costs and manage cash flow through the crisis. One casualty is the final shareholder dividend for 2019. Today’s share price close to 258p is well down from the 680p we saw at the beginning of the year. However, with the lifting of social-distancing restrictions and a return to better levels of business, my guess is the share price will respond well.

We last saw the stock at these levels around 10 years ago. But there’s been a lot of operational progress since then. I’d be willing to take a chance with Meggitt despite the unknowns.

Kevin Godbold has no position in any share mentioned. The Motley Fool UK has recommended Meggitt. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Investing Articles

Are Tesco shares easy money heading into 2026?

The supermarket industry is known for low margins and intense competition. But analysts are bullish on Tesco shares – and…

Read more »

Smiling black woman showing e-ticket on smartphone to white male attendant at airport
Investing Articles

Can this airline stock beat the FTSE 100 again in 2026?

After outperforming the FTSE 100 in 2025, International Consolidated Airlines Group has a promising plan to make its business more…

Read more »

Investing Articles

1 Stocks and Shares ISA mistake that will make me a better investor in 2026

All investors make mistakes. The best ones learn from them. That’s Stephen Wright’s plan to maximise returns from his Stocks…

Read more »

Portrait Of Senior Couple Climbing Hill On Hike Through Countryside In Lake District UK Together
Investing Articles

I asked ChatGPT if £20,000 would work harder in an ISA or SIPP in 2026 and it said…

Investors have two tax-efficient ways to build wealth, either in a Stocks and Shares ISA or SIPP. Harvey Jones asked…

Read more »

Investing Articles

How much would I need invested in an ISA to earn £2,417 a month in passive income?

This writer runs the numbers to see what it takes in an ISA to reach £2,417 a month in passive…

Read more »

Investing Articles

Rolls-Royce shares or Melrose Industries: Which one is better value for 2026?

Rolls-Royce shares surged in 2025, surpassing most expectations. Dr James Fox considers whether it offers better value than peer Melrose.

Read more »

Investing Articles

3 top Vanguard ETFs to consider for an ISA or SIPP in 2026

Edward Sheldon believes that these three Vanguard ETFs could be solid investments for a pension (SIPP) or investment account in…

Read more »

Investing Articles

5 growth stocks on Dr James Fox’s watchlist for 2026

Dr James Fox believes these UK and US growth stocks are worth considering as he looks to outperform the stock…

Read more »